1700041C23Rik Inhibitors is a complex and diverse group of compounds, each designed to modulate the activity of the protein encoded by the gene 1700041C23Rik. These inhibitors, while not directly targeting the protein in a conventional sense, play a crucial role in influencing the biochemical pathways and cellular processes in which 1700041C23Rik is involved. The chemical structures within this class are varied, reflecting the multifaceted nature of their mechanisms of action. This diversity is key to their ability to interact with different aspects of cellular function, thereby indirectly affecting the activity of 1700041C23Rik. For instance, kinase inhibitors within this group, such as Staurosporine, function by disrupting phosphorylation processes, a fundamental method of cellular regulation and signaling. This action can cascade down to influence the activity of 1700041C23Rik, given its potential involvement in such pathways. Similarly, compounds like LY294002, a PI3K inhibitor, and Rapamycin, an mTOR inhibitor, operate within major signaling networks, thereby modulating processes that might intersect with the functional domain of 1700041C23Rik.
The development and study of 1700041C23Rik Inhibitors encompass a broad spectrum of scientific inquiry, integrating disciplines such as molecular biology, biochemistry, and pharmacology. Advanced computational methods are often employed in the design and optimization of these compounds, enabling researchers to model interactions at the molecular level and predict potential efficacy. Synthesis of these molecules typically involves complex chemical processes, tailored to produce substances that can penetrate cellular environments and interact with target pathways effectively. Experimental studies, including cellular assays and biochemical evaluations, are essential to validate the effects of these inhibitors. By altering specific signaling cascades or modulatory processes, these compounds can elucidate the functional roles of 1700041C23Rik in various cellular contexts. The study of these inhibitors not only sheds light on the protein's activity but also contributes to a deeper understanding of cellular regulatory mechanisms.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Kinase inhibitor, can disrupt phosphorylation processes potentially involving 1700041C23Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor, can impact the PI3K/Akt signaling pathway, potentially affecting 1700041C23Rik. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor, can influence cell growth and autophagy, potentially impacting 1700041C23Rik. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
HDAC inhibitor, can modify gene expression and chromatin structure, potentially affecting 1700041C23Rik. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MAPK/ERK pathway inhibitor, can alter cell signaling processes involving 1700041C23Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor, can disrupt stress response and inflammation, potentially linked to 1700041C23Rik. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
JNK inhibitor, can alter stress response and apoptosis, potentially involving 1700041C23Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor, can disrupt various signaling pathways potentially linked to 1700041C23Rik. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor, can influence protein degradation, potentially impacting 1700041C23Rik. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Calcium channel blocker, can alter calcium signaling, potentially affecting 1700041C23Rik. |